HomeHUMAW • NASDAQ
add
Humacyte
Previous close
$0.22
Day range
$0.21 - $0.24
Year range
$0.16 - $2.38
Market cap
312.28M USD
Avg Volume
20.97K
P/E ratio
-
Dividend yield
-
In the news
Stock Titan
1 hour ago
Humacyte (NASDAQ: HUMA) says Symvess matches vein in limb trauma; 86.6% patency
0.00%
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 301.00K | — |
Operating expense | 7.81M | 35.90% |
Net income | -37.66M | 33.54% |
Net profit margin | -12.51K | — |
Earnings per share | -0.21 | 56.86% |
EBITDA | -27.87M | -0.53% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 38.03M | -59.35% |
Total assets | 138.80M | 0.37% |
Total liabilities | 134.74M | -19.11% |
Total equity | 4.05M | — |
Shares outstanding | 158.37M | — |
Price to book | 7.34 | — |
Return on assets | -49.32% | — |
Return on capital | -71.95% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -37.66M | 33.54% |
Cash from operations | -26.41M | -24.06% |
Cash from investing | -568.00K | -208.70% |
Cash from financing | 2.17M | 563.81% |
Net change in cash | -24.82M | -13.09% |
Free cash flow | -18.74M | -38.65% |
About
Founded
Jan 1, 2004
Website
Employees
219
